U.S. jury orders AbbVie to pay $3 million in AndroGel retrial

NEW YORK (Reuters) – A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.


Source: Reuters Medical News

Singapore pharma on recovery path after worst output in decades

SINGAPORE (Reuters) – Singapore’s pharmaceuticals business, among the pillars of the city-state’s manufacturing sector, is set to return to strength this year as big global drugmakers ramp up output and advance automation at their production sites across the country.


Source: Reuters Medical News

Israel to launch Big Data health project

JERUSALEM (Reuters) – Israel will invest nearly 1 billion shekels ($287 million) in a project to make data about the state of health of its population available to researchers and private companies, Prime Minister Benjamin Netanyahu said on Sunday.


Source: Reuters Medical News